Literature DB >> 8043943

Acquired immunodeficiency syndrome in the elderly.

W H Adler1, J E Nagel.   

Abstract

Recent data from the US show that since 1990 the number of paediatric patients with AIDS is decreasing while the number of patients with AIDS over age 50 years is increasing. To date, little attention has been given to understanding AIDS risk-taking behaviours, clinical presentations, and therapeutic needs of middle-aged and older HIV-infected individuals. Older HIV-infected individuals deteriorate more rapidly than younger patients due to an accelerated loss of CD4+ helper T cells. Despite recognised age-related physiological differences between young and elderly individuals, scant information about drug optimisation for the treatment of AIDS in older individuals is available. More data need to be collected about this group of AIDS patients, and appropriate treatment strategies designed for their special needs.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8043943     DOI: 10.2165/00002512-199404050-00006

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  32 in total

1.  Restoration of impaired immune functions in aging animals. II. Effect of syngeneic thymus and bone marrow grafts.

Authors:  K Hirokawa; J W Albright; T Makinodan
Journal:  Clin Immunol Immunopathol       Date:  1976-05

2.  Risk of human immunodeficiency virus transmission from heterosexual adults with transfusion-associated infections.

Authors:  T A Peterman; R L Stoneburner; J R Allen; H W Jaffe; J W Curran
Journal:  JAMA       Date:  1988-01-01       Impact factor: 56.272

3.  Influenza: its control in persons and populations.

Authors:  R B Couch; J A Kasel; W P Glezen; T R Cate; H R Six; L H Taber; A L Frank; S B Greenberg; J M Zahradnik; W A Keitel
Journal:  J Infect Dis       Date:  1986-03       Impact factor: 5.226

4.  More rapid progression to AIDS in older HIV-infected people: the role of CD4+ T-cell counts.

Authors:  A N Phillips; C A Lee; J Elford; A Webster; G Janossy; A Timms; M Bofill; P B Kernoff
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1991

Review 5.  Therapy for human immunodeficiency virus infection.

Authors:  M S Hirsch; R T D'Aquila
Journal:  N Engl J Med       Date:  1993-06-10       Impact factor: 91.245

6.  Transfusion-acquired human immunodeficiency virus infection among immunocompromised persons.

Authors:  K C Anderson; B C Gorgone; R G Marlink; R Ferriani; M E Essex; P M Benz; J E Groopman
Journal:  Ann Intern Med       Date:  1986-10       Impact factor: 25.391

7.  HIV infection in patients over 55 years of age.

Authors:  S Ferro; I E Salit
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1992

8.  Incubation period of AIDS in patients infected via blood transfusion.

Authors:  G F Medley; R M Anderson; D R Cox; L Billard
Journal:  Nature       Date:  1987 Aug 20-26       Impact factor: 49.962

9.  Male-to-female transmission of human immunodeficiency virus.

Authors:  N Padian; L Marquis; D P Francis; R E Anderson; G W Rutherford; P M O'Malley; W Winkelstein
Journal:  JAMA       Date:  1987-08-14       Impact factor: 56.272

10.  HIV transmission by blood transfusions in Stockholm 1979-1985: nearly uniform transmission from infected donors.

Authors:  O Berglund; S Beckman; L Grillner; B Jansson; P Lidbrink; A Karlsson; L Morfeldt-Månsson; P O Pehrson; M Törngren; B Wiechel
Journal:  AIDS       Date:  1988-02       Impact factor: 4.177

View more
  4 in total

1.  Aging in AIDS; AIDS and aging.

Authors:  A C Justice; C Whalen
Journal:  J Gen Intern Med       Date:  1996-10       Impact factor: 5.128

Review 2.  HIV disease and advanced age: an increasing therapeutic challenge.

Authors:  Roberto Manfredi
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

3.  Acquired immunodeficiency syndrome in older African Americans.

Authors:  Allen S Funnyé; Abbasi J Akhtar; Gisele Biamby
Journal:  J Natl Med Assoc       Date:  2002-04       Impact factor: 1.798

Review 4.  Immunodeficiency of aging.

Authors:  E A Burns; J S Goodwin
Journal:  Drugs Aging       Date:  1997-11       Impact factor: 4.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.